Evotec SE (EVT) NPV

Sell:€8.60Buy:€8.62€0.31 (3.68%)

Prices delayed by at least 15 minutes
Sell:€8.60
Buy:€8.62
Change:€0.31 (3.68%)
Prices delayed by at least 15 minutes
Sell:€8.60
Buy:€8.62
Change:€0.31 (3.68%)
Prices delayed by at least 15 minutes

Company Information

About this company

Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.

Key people

Iris Loew-Friedrich
Independent Chairwoman of the Supervisory Board
Christian Wojczewski
Chief Executive Officer, Member of the Management Board
Roland Sackers
Independent Vice Chairman of the Supervisory Board
Laetitia Rouxel
Chief Financial Officer, Member of the Management Board
Aurelie Dalbiez
Chief People Officer, Member of the Management Board
Cord Dohrmann
Chief Scientific Officer, Member of the Management Board
Camilla Macapili Languille
Independent Member of the Supervisory Board
Constanze Ulmer-Eilfort
Independent Member of the Supervisory Board
Duncan Mchale
Member of the Supervisory Board
Wesley Wheeler
Member of the Supervisory Board
Click to see more

Key facts

  • EPIC
    -
  • Location
    Germany
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    DE0005664809
  • Market cap
    €1.48bn
  • Employees
    5,007
  • Shares in issue
    177.55m
  • Exchange
    XETRA
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.